ECOR electroCore, Inc.

Nasdaq Electromedical & Electrotherapeutic Apparatus DE CIK: 0001560258
AI RATING
STRONG_SELL
88% Confidence

Investment Thesis

electroCore demonstrates strong revenue growth of 27.2% YoY with exceptional 87.3% gross margins, indicating market demand for its products. However, the company faces critical financial distress with negative stockholders' equity (-5.7M), negative operating cash flow (-3.0M), and accelerating net losses. At current burn rates with minimal liquidity runway, the company faces existential solvency risk without immediate profitability achievement or capital restructuring.

Strengths

  • + Strong revenue growth of 27.2% YoY demonstrates market demand for electromedical technology
  • + Exceptional 87.3% gross margin indicates strong product economics and customer willingness to pay
  • + Cash position of 4.9M provides near-term operational liquidity

Risks

  • ! Negative stockholders' equity of -5.7M represents technical insolvency and existential bankruptcy risk
  • ! Negative operating cash flow of -3.0M with accelerating losses demonstrates unsustainable unit economics
  • ! Critically tight liquidity with current ratio of 1.02x and quick ratio of 0.86x limits refinancing options
  • ! Long-term debt of 7.8M against cash of 4.9M creates near-term refinancing and covenant compliance risk

Key Metrics to Watch

Financial Metrics

Revenue
9.6M
Net Income
-5.3M
EPS (Diluted)
$-0.59
Free Cash Flow
-3.0M
Total Assets
15.5M
Cash
4.9M

Profitability Ratios

Gross Margin 87.3%
Operating Margin -55.5%
Net Margin -55.0%
ROE N/A
ROA -34.0%
FCF Margin -31.4%

Balance Sheet & Liquidity

Current Ratio
1.02x
Quick Ratio
0.86x
Debt/Equity
N/A
Debt/Assets
136.7%
Interest Coverage
-1,329.00x
Long-term Debt
7.8M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-08T10:02:33.456891 | Data as of: 2026-03-31 | Powered by Claude AI